Dorsey Wright & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
|
|||||
2024
Q3 | $7.4M | Buy |
|
|||||
2024
Q2 | $7.79M | Sell |
|
|||||
2024
Q1 | $7.25M | Sell |
|
|||||
2023
Q4 | $6.18M | Sell |
|
|||||
2023
Q3 | $5.86M | Sell |
|
|||||
2023
Q2 | $5.55M | Sell |
|
|||||
2023
Q1 | $6M | Sell |
|
|||||
2022
Q4 | $5.44M | Buy |
|
|||||
2022
Q2 | $4.98M | Sell |
|
|||||
2022
Q1 | $5.55M | Sell |
|
|||||
2021
Q4 | $5.77M | Buy |
|
|||||
2021
Q3 | $4.85M | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $4.14M | Sell |
|
|||||
2020
Q3 | $4.17M | Buy |
|
|||||
2020
Q2 | $3.89M | Sell |
|
|||||
2020
Q1 | $3.86M | Buy |
|
|||||
2019
Q4 | $2.67M | Buy |
|
|||||
2013
Q3 | – | Sell |
|
|||||
2013
Q2 | $139K | Buy |
|